Target intelligence / Profile preview

Store-operated calcium entry-associated regulatory factor (SARAF)

Target
SARAF
Molecular classification
Other, Regulatory protein, Single-pass transmembrane protein, Endoplasmic reticulum membrane protein
01

Overview

Store-operated calcium entry-associated regulatory factor (SARAF) is a single-pass transmembrane protein primarily located in the endoplasmic reticulum membrane, encoded by the SARAF gene (previously TMEM66). SARAF plays a crucial regulatory role in intracellular calcium signaling by facilitating the slow calcium-dependent inactivation (SCDI) of store-operated calcium entry (SOCE), thus protecting cells from calcium overload. SARAF interacts with stromal interaction molecule 1 (STIM1) and Orai1 to modify calcium channel states, affecting both store-operated (CRAC) and store-independent (ARC) calcium channels. It functions as a negative regulator of cytosolic calcium signals and is also involved in shaping the amplitude and duration of calcium entry in response to stimuli. Altered SARAF expression influences cell survival pathways in cancer models and modulates response to agents such as arachidonic acid and retinoic acid, potentially impacting disease processes in cancer and possibly neurodegeneration[1][2][3].

Other names
TMEM66FOAP-7XTP3HSPC035NPD003PSEC0019UNQ1967/PRO4499SOCE-associated regulatory factorMGC8721HBV X-transactivated gene 3 proteinHBV XAg-transactivated protein 3testicular secretory protein Li 59Transmembrane protein 66
02

Mechanism of action

Not typically a direct drug target; functions by interacting with STIM1, Orai1, and ARC channel subunits to regulate calcium channel inactivation/activation[2][3]

03

Biological functions

Regulation of store-operated calcium entry (SOCE)Calcium homeostasisSignal transductionRegulation of CRAC (Calcium Release-Activated Calcium) channelsNegative regulation of cytosolic calcium signals
04

Disease associations

CancerNeurodegenerative diseaseCell survival/death regulation (evidence of roles in cancer cell survival—studied in neuroblastoma and prostate cancer cells)
05

Safety considerations

No recognized direct safety/toxicity concerns as a therapeutic target; alteration of SARAF function can influence cellular calcium homeostasis, potentially affecting cell viability and signaling
06

Interacting drugs

None clearly established; but SARAF modulates responses to arachidonic acid and all-trans retinoic acid (ATRA) in experimental systems[3]
07

Biomarkers

None established for clinical use

Beyond the preview

Go deeper on Store-operated calcium entry-associated regulatory factor (SARAF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Store-operated calcium entry-associated regulatory factor (SARAF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call